Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 13, 2019 - Issue
Submit an article Journal homepage
197
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy

Wen-Yan Wang1 Department of Obstetrics and Gynecology, The Second Hospital of Anhui Medical University, Hefei, Anhui, 230601, People’s Republic of China;2 Teaching and Research Group of Obstetrics and Gynecology, Anhui Medical University, Hefei, Anhui, 230032, People’s Republic of China
,
Yun-Xia Cao2 Teaching and Research Group of Obstetrics and Gynecology, Anhui Medical University, Hefei, Anhui, 230032, People’s Republic of ChinaCorrespondence[email protected]
,
Xiao Zhou3 Department of Cardiothoracic Surgery, The Second Hospital of Anhui Medical University, Hefei, Anhui, 230601, People’s Republic of China
&
Bing Wei1 Department of Obstetrics and Gynecology, The Second Hospital of Anhui Medical University, Hefei, Anhui, 230601, People’s Republic of China
Pages 2205-2213 | Published online: 04 Jul 2019

References

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.2010721296855
  • Di J, Rutherford S, Chu C. Review of the cervical cancer burden and population-based cervical cancer screening in China. Asian Pac J Cancer Prev. 2015;16(17):7401–7407.26625735
  • Ramakrishnan S, Partricia S, Mathan G. Overview of high-riskHPV’s 16 and 18 infected cervical cancer: pathogenesis to prevention. Biomed Pharmacother. 2015;70:103–110. doi:10.1016/j.biopha.2014.12.04125776487
  • Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340(15):1144–1153. doi:10.1056/NEJM19990415340150210202165
  • Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aorticradiation for high-risk cervical cancer. N Engl J Med. 1999;340(15):1137–1143. doi:10.1056/NEJM19990415340150110202164
  • Segovia-Mendoza M, Jurado R, Mir R, et al. Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and In vivo Study. BMC Cancer. 2015;15:21. doi:10.1186/s12885-015-1584-325622528
  • Chattopadhyay I, Biswas K, Bandyopadhyay U, et al. Turmeric and curcumin biological actions and medicinal applications. Curr Sci. 2004;87:44–50.
  • Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of 18rcumin: a short review. Life Sci. 2006;78(18):2081–2087. doi:10.1016/j.lfs.2005.12.00716413584
  • Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer. 2006;106(11):2503–2513. doi:10.1002/cncr.2190416628653
  • Sa G, Das T. Anticancer effects of curcumin: cycle of life and death. Cell Div. 2017;3:14. doi:10.1186/1747-1028-3-14
  • Adahoun MA, A-Akhras MH, Jaafar MS, Bououdina M. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. Artif Cells Nanomed Biotechnol. 2017;45(1):98–107. doi:10.3109/21691401.2015.112962826747522
  • Chaudhury A, Tan BJ, Das S, Chiu GNC. Increased ERK activation and cellular drug accumulation in the enhanced cytotoxicity of folate receptor-targeted liposomal carboplatin. Int J Oncol. 2012;40(3):703–710. doi:10.3892/ijo.2011.126222086152
  • Watanabe K, Kaneko M, Maitani Y. Functional coating of liposomes using a folate-polymer conjugate to target folate receptors. Int J Nanomedicine. 2012;7:3679–3688. doi:10.2147/IJN.S3285322888227
  • Liu Y, Xu S, Teng L, et al. Synthesis and evaluation of a novel lipophilic folate receptor targeting ligand. Anticancer Res. 2011;31(5):1521–1525.21617205
  • Xiong S, Yu B, Wu J, Li H, Lee RJ. Preparation, therapeutic efficacy and intratumoral localization of targeted daunorubicin liposomes conjugating folate-PEG-CHEMS. Biomed Pharmacother. 2011;65(1):2–8. doi:10.1016/j.biopha.2010.10.00321177069
  • Hilgenbrink AR, Low PS. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci. 2005;94(10):2135–2146. doi:10.1002/jps.2045716136558
  • Lu Y, Ding N, Yang C, Huang L, Liu J, Xiang G. Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation. J Liposome Res. 2012;22(2):110–119. doi:10.3109/08982104.2011.62751422372871
  • Sabharanjak S, Mayor S. Folate receptor endocytosis and trafficking. Adv Drug Deliv Rev. 2004;56(8):1099–1109. doi:10.1016/j.addr.2004.01.01015094209
  • Daeihamed M, Dadashzadeh S, Haeri A, et al. Potential of liposomes for enhancement of oral drug absorption. Curr Drug Deliv. 2016;14:289–303.
  • Zhang HX, Wang JX, Zhang ZB, Le Y, Shen ZG, Chen JF. Micronization of atorvastatin calcium by antisolvent precipitation process. Int J Pharm. 2009;374(1–2):106–113. doi:10.1016/j.ijpharm.2009.02.01519446766
  • Hinrichs WL, Mancenido FA, Sanders NN, et al. The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying. Int J Pharm. 2006;311(1–2):237–244. doi:10.1016/j.ijpharm.2005.12.03216442758
  • Sreekanth CN, Bava SV, Sreekumar E, Anto RJ. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer. Oncogene. 2011;30:3139–3152. doi:10.1038/onc.2011.2321317920

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.